2020TS
2021-11-30
Get your price correct, $530/tablet, it's day light robbery.
Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant<blockquote>辉瑞计划提高新冠药物产量以对抗奥密克戎病毒变种，股价上涨</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":609989381,"tweetId":"609989381","gmtCreate":1638231322546,"gmtModify":1638231323053,"author":{"id":3568580098685907,"idStr":"3568580098685907","authorId":3568580098685907,"authorIdStr":"3568580098685907","name":"2020TS","avatar":"https://static.tigerbbs.com/dc251ae3d7264077ed6557978fbfc6bb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":28,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Get your price correct, $530/tablet, it's day light robbery.</p></body></html>","htmlText":"<html><head></head><body><p>Get your price correct, $530/tablet, it's day light robbery.</p></body></html>","text":"Get your price correct, $530/tablet, it's day light robbery.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/609989381","repostId":1188274579,"repostType":4,"repost":{"id":"1188274579","kind":"news","pubTimestamp":1638192806,"share":"https://www.laohu8.com/m/news/1188274579?lang=zh_CN&edition=full","pubTime":"2021-11-29 21:33","market":"us","language":"en","title":"Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant<blockquote>辉瑞计划提高新冠药物产量以对抗奥密克戎病毒变种，股价上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188274579","media":"TheStreet","summary":"Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivri","content":"<p>Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.</p><p><blockquote>辉瑞首席执行官Albert Bourla证实，该制药商计划提高其Paxlovid抗病毒治疗药物的产量，这是针对新奥密克戎病毒变种传播的第一步。</blockquote></p><p> Pfizer shares extended gains Monday after the drugmaker said it's preparing to boost production of its Covid antiviral treatment to combat the potential impact of the newly-discovered Omicron variant.</p><p><blockquote>辉瑞表示，正准备提高新冠抗病毒治疗的产量，以应对新发现的奥密克戎病毒变种的潜在影响，该公司股价周一扩大涨幅。</blockquote></p><p> Pfizer CEO Albert Bourla told CNBC Monday that the drugmaker has committed to making 80 million doses of Paxlovid, its developing antiviral, up from its prior forecast of 50 million.</p><p><blockquote>辉瑞首席执行官Albert Bourla周一告诉CNBC，该制药商已承诺生产8000万剂其正在开发的抗病毒药物Paxlovid，高于之前预测的5000万剂。</blockquote></p><p> The antiviral treatment may continue to be an effective defense against the variant, which was first identified in South Africa, even as scientists remain concerned that it may be resistant to both vaccine structures and natural immunity.</p><p><blockquote>抗病毒治疗可能继续是对这种变异的有效防御，这种变异首先在南非被发现，尽管科学家仍然担心它可能对疫苗结构和天然免疫都有耐药性。</blockquote></p><p> Bourla also said that Pfizer has created a new template that could speed the development of a new vaccine to combat Omicron if needed, adding the drugmaker has the capability to make as many as 4 billion doses next year.</p><p><blockquote>Bourla还表示，辉瑞已经创建了一个新模板，如果需要，可以加快对抗奥密克戎病毒的新疫苗的开发，并补充说该制药商明年有能力生产多达40亿剂疫苗。</blockquote></p><p> Scientists and health officials have yet to determine if Omicron is vaccine resistant, with the World Health Organization cautioning that it could take \"several weeks\" to assess its full potential.</p><p><blockquote>科学家和卫生官员尚未确定奥密克戎病毒是否对疫苗产生耐药性，世界卫生组织警告说，可能需要“几周时间”才能评估其全部潜力。</blockquote></p><p> Pfizer shares were marked 1.85% higher in pre-market trading Monday to indicate an opening bell price of $55.0 each. The stock hit an all-time high of $54.94 in mid-day trading on Friday.</p><p><blockquote>辉瑞股价周一盘前交易中上涨1.85%，开盘价为每股55.0美元。该股在周五午盘交易中触及54.94美元的历史新高。</blockquote></p><p> Earlier this month, Pfizer said it will sell around 10 million of its Paxlovid treatment,which is currently being reviewed for Emergency Use Approval (EUA) by the U.S. Food & Drug Administration, to the United States Department of Health and Human Services.</p><p><blockquote>本月早些时候，辉瑞表示将向美国卫生与公众服务部出售约1000万剂Paxlovid治疗药物，该药物目前正在接受美国食品和药物管理局的紧急使用批准(EUA)审查。</blockquote></p><p> At $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck & Co. MRK last month to buy 1.7 million doses its 'molnupiravir' treatment of \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.</p><p><blockquote>每片530美元，比上个月与默克公司（Merck&Co.）达成的700美元的价格便宜约25%。MRK购买了170万剂“molnupiravir”，用于治疗有发展为严重疾病或住院风险的成年人的轻度至中度Covid。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant<blockquote>辉瑞计划提高新冠药物产量以对抗奥密克戎病毒变种，股价上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant<blockquote>辉瑞计划提高新冠药物产量以对抗奥密克戎病毒变种，股价上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-11-29 21:33</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.</p><p><blockquote>辉瑞首席执行官Albert Bourla证实，该制药商计划提高其Paxlovid抗病毒治疗药物的产量，这是针对新奥密克戎病毒变种传播的第一步。</blockquote></p><p> Pfizer shares extended gains Monday after the drugmaker said it's preparing to boost production of its Covid antiviral treatment to combat the potential impact of the newly-discovered Omicron variant.</p><p><blockquote>辉瑞表示，正准备提高新冠抗病毒治疗的产量，以应对新发现的奥密克戎病毒变种的潜在影响，该公司股价周一扩大涨幅。</blockquote></p><p> Pfizer CEO Albert Bourla told CNBC Monday that the drugmaker has committed to making 80 million doses of Paxlovid, its developing antiviral, up from its prior forecast of 50 million.</p><p><blockquote>辉瑞首席执行官Albert Bourla周一告诉CNBC，该制药商已承诺生产8000万剂其正在开发的抗病毒药物Paxlovid，高于之前预测的5000万剂。</blockquote></p><p> The antiviral treatment may continue to be an effective defense against the variant, which was first identified in South Africa, even as scientists remain concerned that it may be resistant to both vaccine structures and natural immunity.</p><p><blockquote>抗病毒治疗可能继续是对这种变异的有效防御，这种变异首先在南非被发现，尽管科学家仍然担心它可能对疫苗结构和天然免疫都有耐药性。</blockquote></p><p> Bourla also said that Pfizer has created a new template that could speed the development of a new vaccine to combat Omicron if needed, adding the drugmaker has the capability to make as many as 4 billion doses next year.</p><p><blockquote>Bourla还表示，辉瑞已经创建了一个新模板，如果需要，可以加快对抗奥密克戎病毒的新疫苗的开发，并补充说该制药商明年有能力生产多达40亿剂疫苗。</blockquote></p><p> Scientists and health officials have yet to determine if Omicron is vaccine resistant, with the World Health Organization cautioning that it could take \"several weeks\" to assess its full potential.</p><p><blockquote>科学家和卫生官员尚未确定奥密克戎病毒是否对疫苗产生耐药性，世界卫生组织警告说，可能需要“几周时间”才能评估其全部潜力。</blockquote></p><p> Pfizer shares were marked 1.85% higher in pre-market trading Monday to indicate an opening bell price of $55.0 each. The stock hit an all-time high of $54.94 in mid-day trading on Friday.</p><p><blockquote>辉瑞股价周一盘前交易中上涨1.85%，开盘价为每股55.0美元。该股在周五午盘交易中触及54.94美元的历史新高。</blockquote></p><p> Earlier this month, Pfizer said it will sell around 10 million of its Paxlovid treatment,which is currently being reviewed for Emergency Use Approval (EUA) by the U.S. Food & Drug Administration, to the United States Department of Health and Human Services.</p><p><blockquote>本月早些时候，辉瑞表示将向美国卫生与公众服务部出售约1000万剂Paxlovid治疗药物，该药物目前正在接受美国食品和药物管理局的紧急使用批准(EUA)审查。</blockquote></p><p> At $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck & Co. MRK last month to buy 1.7 million doses its 'molnupiravir' treatment of \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.</p><p><blockquote>每片530美元，比上个月与默克公司（Merck&Co.）达成的700美元的价格便宜约25%。MRK购买了170万剂“molnupiravir”，用于治疗有发展为严重疾病或住院风险的成年人的轻度至中度Covid。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/markets/pfizer-stock-jumps-on-covid-pill-production-boost-to-fight-omicron\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.thestreet.com/markets/pfizer-stock-jumps-on-covid-pill-production-boost-to-fight-omicron","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188274579","content_text":"Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.\nPfizer shares extended gains Monday after the drugmaker said it's preparing to boost production of its Covid antiviral treatment to combat the potential impact of the newly-discovered Omicron variant.\nPfizer CEO Albert Bourla told CNBC Monday that the drugmaker has committed to making 80 million doses of Paxlovid, its developing antiviral, up from its prior forecast of 50 million.\nThe antiviral treatment may continue to be an effective defense against the variant, which was first identified in South Africa, even as scientists remain concerned that it may be resistant to both vaccine structures and natural immunity.\nBourla also said that Pfizer has created a new template that could speed the development of a new vaccine to combat Omicron if needed, adding the drugmaker has the capability to make as many as 4 billion doses next year.\nScientists and health officials have yet to determine if Omicron is vaccine resistant, with the World Health Organization cautioning that it could take \"several weeks\" to assess its full potential.\nPfizer shares were marked 1.85% higher in pre-market trading Monday to indicate an opening bell price of $55.0 each. The stock hit an all-time high of $54.94 in mid-day trading on Friday.\nEarlier this month, Pfizer said it will sell around 10 million of its Paxlovid treatment,which is currently being reviewed for Emergency Use Approval (EUA) by the U.S. Food & Drug Administration, to the United States Department of Health and Human Services.\nAt $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck & Co. MRK last month to buy 1.7 million doses its 'molnupiravir' treatment of \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1001,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["08100"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":52,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/609989381"}
精彩评论